4DMedical (ASX:4DX) Retained Earnings: A$-336.25 Mil (As of Dec. 2025)


ASX:4DX 4DMedical Ltd ASX:4DX
64 GF Score
Price A$4.06
GF Value A$1.45
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is 4DMedical Retained Earnings?

4DMedical ASX:4DX -0.98% 64 Retained Earnings is A$-336.25 Mil as of Dec. 2025. GuruFocus rates ASX:4DX with a GF Score™ of 64/100 and a GF Value™ of A$1.45 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. 4DMedical's retained earnings for the quarter that ended in Dec. 2025 was A$-336.25 Mil.

4DMedical's quarterly retained earnings declined from Dec. 2024 (A$-163.32 Mil) to Jun. 2025 (A$-182.11 Mil) and declined from Jun. 2025 (A$-182.11 Mil) to Dec. 2025 (A$-336.25 Mil).

4DMedical's annual retained earnings declined from Jun. 2023 (A$-116.06 Mil) to Jun. 2024 (A$-152.04 Mil) and declined from Jun. 2024 (A$-152.04 Mil) to Jun. 2025 (A$-182.11 Mil).


4DMedical  (ASX:4DX) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


4DMedical Retained Earnings Historical Data

* Premium members only.

The historical data trend for 4DMedical's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4DMedical Retained Earnings Chart

4DMedical Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Retained Earnings
Get a 7-Day Free Trial -60.01 -84.60 -116.06 -152.04 -182.11

4DMedical Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -131.67 -152.04 -163.32 -182.11 -336.25
ASX:4DX
64GF Score
4DMedical Ltd ASX:4DX
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

4DMedical Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of A$-336.25 Mil mean?
4DMedical (ASX:4DX) has a Retained Earnings of A$-336.25 Mil as of Dec. 2025. Retained earnings is the amount of net income not issued to shareholders. View historical data on 4DMedical and its competitors.
Is 4DMedical's Retained Earnings too high?
4DMedical's current Retained Earnings is A$-336.25 Mil. Overall, 4DMedical has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 4DMedical's Retained Earnings compare to ABT and SYK?
4DMedical's Retained Earnings of A$-336.25 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Devices & Instruments company?
A good Retained Earnings depends on the Medical Devices & Instruments industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on 4DMedical and its competitors. 4DMedical's current Retained Earnings is A$-336.25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4DMedical stock overvalued right now?
Based on GuruFocus' analysis, 4DMedical (ASX:4DX) is currently considered Significantly Overvalued. The stock's GF Value™ is A$1.45, compared to a current price of A$4.06 — trading 180% above its estimated fair value. The current Retained Earnings is A$-336.25 Mil. 4DMedical's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For 4DMedical (ASX:4DX), the current Retained Earnings is A$-336.25 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 4DMedical (ASX:4DX) Overvalued in 2026?

Based on GuruFocus' analysis, 4DMedical stock appears to be overvalued. The current stock price of A$4.06 is trading 180% above its estimated GF Value™ of A$1.45. GuruFocus considers 4DMedical to be Significantly Overvalued.

Key valuation signals for ASX:4DX:

  • Retained Earnings: A$-336.25 Mil
  • GF Value™: A$1.45 vs. price of A$4.06 (180% above fair value)
  • GF Score™: 64/100 with 2 warning signs

No single metric tells the full story. See the ASX:4DX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


4DMedical Business Description

Other Exchanges FDMDF:USAMQ7:Germany
Address 700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
64GF Score

Get the complete analysis for ASX:4DX

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$4.06
Price
A$1.45
GF Value